- Home
- PRTA vs FTW Comparison
PRTA vs FTW Comparison
Compare PRTA & FTW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PRTA | FTW |
|---|---|---|
| Founded | 2012 | N/A |
| Country | Ireland | |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 482.3M | 470.2M |
| IPO Year | 2013 | 2024 |
Fundamental Metrics
Financial Performance| Metric | PRTA | FTW |
|---|---|---|
| Price | $9.31 | $10.90 |
| Analyst Decision | Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $19.00 | N/A |
| AVG Volume (30 Days) | ★ 416.4K | 97.2K |
| Earning Date | 05-20-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $814,000.00 | N/A |
| Revenue This Year | $1,111.38 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.32 | $9.50 |
| 52 Week High | $14.34 | $17.20 |
Technical Indicators
Market Signals| Indicator | PRTA | FTW |
|---|---|---|
| Relative Strength Index (RSI) | 49.36 | 47.11 |
| Support Level | $9.07 | $9.50 |
| Resistance Level | $9.59 | $17.20 |
| Average True Range (ATR) | 0.50 | 1.94 |
| MACD | 0.05 | -0.05 |
| Stochastic Oscillator | 44.96 | 20.67 |
Price Performance
Historical ComparisonAbout PRTA Prothena Corporation plc
Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.
About FTW EQV Ventures Acquisition Corp. Class A Ordinary Shares
EQV Ventures Acquisition Corp is a blank check company.